![Liu Hui](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Liu Hui
Director/Board Member at
RALLYBIO CORPORATION
Net worth: - $ as of 30/06/2026
Profile
Liu Hui currently works at Rallybio Corp., as Independent Director from 2022.
Dr. Hui also formerly worked at Novartis AG, as VP & Head-Business Development & Licensing from 2013 to 2015 and Merus NV, as Chief Business Officer & Executive Vice President from 2015 to 2024.
Dr. Hui received his undergraduate degree from Peking University and Masters Business Admin degree and doctorate degree from the University of Michigan.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RALLYBIO CORPORATION -.--% | 19/12/2025 | 0 ( -.--% ) | - $ | 30/06/2026 |
Liu Hui active positions
| Companies | Position | Start |
|---|---|---|
| RALLYBIO CORPORATION | Director/Board Member | 04/04/2022 |
Former positions of Liu Hui
| Companies | Position | End |
|---|---|---|
| MERUS N.V. | Corporate Officer/Principal | 01/07/2024 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2015 |
Training of Liu Hui
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
66
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Novartis AG
 Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
Peking University
 Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
- Stock Market
- Insiders
- Liu Hui
